Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phosphodiesterase 4 Gene Variant and Salbutamol Response in Persistent Childhood Asthma

NCT03592212 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT03592212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03592212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phosphodiesterase 4 Gene Variant and Salbutamol Response in Persistent Childhood Asthma
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Observational
Overall status
Terminated
Start date
November 23, 2018
Completion date
November 14, 2019
Enrollment
99 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma